The new prices were made possible by the Medicare negotiation program created under the Biden administration's Inflation ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...

The Trump administration’s negotiation with Novo Nordisk A/S that slashes 71% off the list price of its blockbusters Ozempic ...

The Trump administration negotiated lower prices on 15 costly drugs under Medicare, including Ozempic and Wegovy.

The US government said Tuesday it negotiated a 71% discount off of the list price of Novo Nordisk A/S’s blockbuster drugs ...

Medicare will cap prices on 15 more drugs, including Ozempic, with cuts starting in 2027 under Trump administration policy.

Shares of Novo Nordisk ($NVO) are up 3% at the time of writing after the Centers for Medicare & Medicaid Services (CMS) ...

CMS has negotiated a 71% discount off the list price, or $274 for a 30-day supply, on Novo Nordisk’s semaglutide products — Ozempic and Rybelsus for diabetes and Wegovy for weight loss — through the ...

Some people taking popular new diabetes and weight-loss drugs including Ozempic, Wegovy, Zepbound and Mounjaro have reported reduced cravings for substances besides food. The medications seem to ...

GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study. Patients on the medications had less than half the mortality rate of ...

Under the agreement, eligible patients will pay around $245 to $350 per month, instead of $1350 a month. HealthDay News — Two major drugmakers will slash the price of popular weight loss medications ...